BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11310966)

  • 21. Immobilization of cationic rifampicin-loaded liposomes on polystyrene for drug-delivery applications.
    Pasquardini L; Lunelli L; Vanzetti L; Anderle M; Pederzolli C
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):265-72. PubMed ID: 18083351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
    El-Samaligy MS; Afifi NN; Mahmoud EA
    Int J Pharm; 2006 Feb; 308(1-2):140-8. PubMed ID: 16356669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome-based drug delivery systems.
    Langner M; Kral TE
    Pol J Pharmacol; 1999; 51(3):211-22. PubMed ID: 10600035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposome-based drug delivery to alveolar macrophages.
    Vyas SP; Khatri K
    Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorinated vesicles.
    Riess JG
    J Drug Target; 1994; 2(5):455-68. PubMed ID: 7704491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of nanoscale multicompartment liposomes for combinatory drug delivery.
    Al-Jamal WT; Kostarelos K
    Int J Pharm; 2007 Mar; 331(2):182-5. PubMed ID: 17223294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
    Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
    Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization, and biological analysis of liposomal formulations of vincristine.
    Waterhouse DN; Madden TD; Cullis PR; Bally MB; Mayer LD; Webb MS
    Methods Enzymol; 2005; 391():40-57. PubMed ID: 15721373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis.
    Han I; Kim M; Kim J
    Exp Dermatol; 2004 Feb; 13(2):86-92. PubMed ID: 15009101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins.
    Seki J; Sonoke S; Saheki A; Koike T; Fukui H; Doi M; Mayumi T
    Int J Pharm; 2004 May; 275(1-2):239-48. PubMed ID: 15081154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for cytosolic delivery of liposomal macromolecules.
    Fretz MM; Mastrobattista E; Koning GA; Jiskoot W; Storm G
    Int J Pharm; 2005 Jul; 298(2):305-9. PubMed ID: 15941633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-coated liposomes for delivery to lungs by nebulisation.
    Zaru M; Manca ML; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.
    Stover T; Kester M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):468-75. PubMed ID: 12975495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current trends in liposome research.
    Elbayoumi TA; Torchilin VP
    Methods Mol Biol; 2010; 605():1-27. PubMed ID: 20072870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes].
    Mao SJ; Hou SX; Jin H; Zhang LK; Jiang-Bin
    Zhongguo Zhong Yao Za Zhi; 2003 Apr; 28(4):328-31. PubMed ID: 15139140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current progress and future prospects of liposomes in dermal drug delivery.
    Moghimi SM; Patel HM
    J Microencapsul; 1993; 10(2):155-62. PubMed ID: 8331490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.